EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Deploying whole blood to the battlefield—The Israel Defense Forces Medical Corps initial experience during the 2023 war

Ofer Almog iD, Avi Benov iD, Zivan Beer, Tsvi Sirotkin, Omri Shental iD, Elon Glassberg

Transfusion · 2024

DOI: 10.1111/trf.17718 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transfusion, 2024. Verfasst von Ofer Almog und 5 weiteren Autor:innen. Beteiligte Einrichtung: Israel Defense Forces Medical Corps, Surgeon General's Headquarters, Ramat Gan, Israel. Hauptthemen laut MEDLINE: Blood Transfusion. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Military and prehospital medical organizations invest significant resources to advance the treatment of trauma patients aiming to reduce preventable deaths. Focus is on hemorrhage control and volume resuscitation with blood products, with adoption of Remote Damage Control Resuscitation (RDCR) guidelines. The Israel Defense Forces Medical Corps (IDF‐MC) has been using tranexamic acid and freeze‐dried plasma (FDP) as part of its RDCR protocol for more than a decade. In recent years, low‐titer group O whole blood (LTOWB) has been integrated, on IDF evacuation helicopters and expanded to mobile ambulances, complementing FDP use in treating trauma patients in state of profound shock. Study Design and Methods During the war that erupted in October 2023, the IDF‐MC made a decision to bring LTOWB forward, and to equip every combat brigade level mobile intensive care units with LTOWB, onboard armored vehicles. The goal was to make whole blood available as close as possible to the point of injury and within minutes from time of injury. Results and Discussion We describe the IDF‐MCs' efforts to bring LTOWB to the front lines and present four cases in which LTOWB was administered. All patients were young male, with significant blood loss following penetrating injuries. One patient died in the operating room, following hospital arrival and emergency thoracotomy. The others survived. Our initial experience with bringing LTOWB as close as possible to the point of injury during high intensity fighting is encouraging, showing patient benefit along with logistic feasibility. After action reports and data collection will continue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood TransfusionAdultHumansMaleIsraelMilitary MedicineMilitary PersonnelResuscitationWarfareWounds and Injuries

Stichwörter der Autor:innen

low titer group O whole bloodprehospitalremote damage control resuscitationshocktraumawhole blood

Autor:innen und Institutionen

  • Israel Defense Forces Medical Corps, Surgeon General's Headquarters, Ramat Gan, Israel.
  • Department of Military Medicine, Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • The Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.

ORCID-Profile: Ofer Almog, Avi Benov, Omri Shental

Zitieren

APA

Almog, O., Benov, A., Beer, Z., Sirotkin, T., Shental, O., & Glassberg, E. (2024). Deploying whole blood to the battlefield—The Israel Defense Forces Medical Corps initial experience during the 2023 war. Transfusion. https://doi.org/10.1111/trf.17718

Vancouver

Almog O, Benov A, Beer Z, Sirotkin T, Shental O, Glassberg E. Deploying whole blood to the battlefield—The Israel Defense Forces Medical Corps initial experience during the 2023 war. Transfusion. 2024. doi:10.1111/trf.17718

BibTeX
@article{Almog2024,
  author = {Almog, Ofer and Benov, Avi and Beer, Zivan and Sirotkin, Tsvi and Shental, Omri and Glassberg, Elon},
  title = {Deploying whole blood to the battlefield—The Israel Defense Forces Medical Corps initial experience during the 2023 war},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17718}
}
Kostenlos starten →